These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
44. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Lang S; Mary-Krause M; Simon A; Partisani M; Gilquin J; Cotte L; Boccara F; Costagliola D; Clin Infect Dis; 2012 Aug; 55(4):600-7. PubMed ID: 22610928 [TBL] [Abstract][Full Text] [Related]
45. [Aging and influence of inversion of the CD4:CD8 ratio in the incidence of co-morbidities and mortality in a cohort of patients infected with human immunodeficiency virus]. Cervero M; Torres R; Agud JL; Pastor S; Jusdado JJ Med Clin (Barc); 2016 Mar; 146(5):189-93. PubMed ID: 26726112 [TBL] [Abstract][Full Text] [Related]
46. CD4/CD8 ratio, comorbidities, and aging in treated HIV infected individuals on viral suppression. Passos DF; Bremm JM; da Silveira LL; Jantsch MH; da Silva JLG; Disconzi E; Rezer JFP; Schwarzbold AV; Marques ACF; Schetinger MRC; Leal DBR J Med Virol; 2020 Dec; 92(12):3254-3264. PubMed ID: 32314818 [TBL] [Abstract][Full Text] [Related]
47. Incipient renal impairment as a predictor of subclinical atherosclerosis in HIV-infected patients. Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; Sánchez-Parra C; Sainz T; Patiño R; Fernández-Cruz A J Acquir Immune Defic Syndr; 2012 Feb; 59(2):141-8. PubMed ID: 22107820 [TBL] [Abstract][Full Text] [Related]
48. Cross-sectional study of CD4: CD8 ratio recovery in young adults with perinatally acquired HIV-1 infection. Pollock KM; Pintilie H; Foster C; Fidler S Medicine (Baltimore); 2018 Feb; 97(8):e9798. PubMed ID: 29465561 [TBL] [Abstract][Full Text] [Related]
49. CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. Aldrete S; Jang JH; Easley KA; Okulicz J; Dai T; Chen YN; Pino M; Agan BK; Maves RC; Paiardini M; Marconi VC PLoS One; 2020; 15(1):e0227124. PubMed ID: 31905222 [TBL] [Abstract][Full Text] [Related]
50. Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study. Francis-Morris A; Mackie NE; Eliahoo J; Ramzan F; Fidler S; Pollock KM HIV Med; 2020 Feb; 21(2):109-118. PubMed ID: 31617962 [TBL] [Abstract][Full Text] [Related]
51. Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy. Jeong SJ; Song JE; Kim SB; Kim HW; Ku NS; Han SH; Choi JY; Song YG; Cha BS; Kim JM AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1575-81. PubMed ID: 23941507 [TBL] [Abstract][Full Text] [Related]
52. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening. Alcaraz MJ; Alcaraz A; Teruel-Montoya R; Campillo JA; de la Torre A; Muñoz Á; Tomás C; Puche G; Báguena C; Cano A; Minguela A; Bernal E Aging (Albany NY); 2021 Jul; 13(14):18094-18105. PubMed ID: 34310343 [TBL] [Abstract][Full Text] [Related]
53. Frailty and physical function in older HIV-infected adults. Brañas F; Jiménez Z; Sánchez-Conde M; Dronda F; López-Bernaldo De Quirós JC; Pérez-Elías MJ; Miralles P; Ramírez M; Moreno A; Berenguer J; Moreno S Age Ageing; 2017 May; 46(3):522-526. PubMed ID: 28203694 [TBL] [Abstract][Full Text] [Related]
54. A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV. Triplette M; Attia EF; Akgün KM; Soo Hoo GW; Freiberg MS; Butt AA; Wongtrakool C; Goetz MB; Brown ST; Graber CJ; Huang L; Crothers K PLoS One; 2017; 12(1):e0170857. PubMed ID: 28122034 [TBL] [Abstract][Full Text] [Related]
55. Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India. Kausalya B; Saravanan S; Pallikkuth S; Pahwa R; Saini SR; Iqbal S; Solomon S; Murugavel KG; Poongulali S; Kumarasamy N; Pahwa S BMC Immunol; 2022 May; 23(1):24. PubMed ID: 35581554 [TBL] [Abstract][Full Text] [Related]
56. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. D'Abramo A; Zingaropoli MA; Oliva A; D'Agostino C; Al Moghazi S; De Luca G; Iannetta M; Mastroianni CM; Vullo V Mediators Inflamm; 2014; 2014():192594. PubMed ID: 25374442 [TBL] [Abstract][Full Text] [Related]
57. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence. Jiménez B; Sainz T; Díaz L; Mellado MJ; Navarro ML; Rojo P; González-Tomé MI; Prieto L; Martínez J; de José MI; Ramos JT; Muñoz-Fernandez MÁ; Pediatr Infect Dis J; 2017 Jun; 36(6):578-583. PubMed ID: 28005690 [TBL] [Abstract][Full Text] [Related]
58. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV. Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605 [TBL] [Abstract][Full Text] [Related]
59. Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH Study. Sainz T; Álvarez-Fuente M; Navarro ML; Díaz L; Rojo P; Blázquez D; de José MI; Ramos JT; Serrano-Villar S; Martínez J; Medrano C; Muñoz-Fernández MÁ; Mellado MJ; J Acquir Immune Defic Syndr; 2014 Jan; 65(1):42-9. PubMed ID: 23982657 [TBL] [Abstract][Full Text] [Related]
60. Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study. Rawson TM; Dubb S; Pozniak A; Kelleher WP; Mandalia S; Gazzard B; Barber TJ Int J STD AIDS; 2015 Feb; 26(2):128-32. PubMed ID: 24759562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]